𝔖 Bobbio Scriptorium

✦ LIBER ✦

Rejection to several technologies for eternal preservation of self in patients with advanced lung cancer in a northwestern region of Japan

✍ Scribed by Seino, Shuichi

Book ID: 118570483
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 114 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80938-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic factors for survival in a Chi

Prognostic factors for survival in a Chinese population presenting with advanced non-small cell lung cancer with an emphasis on smoking status: A regional, single-institution, retrospective analysis of 4552 patients

✍ Qiong Hu; Bing Li; David Garfield; Shengxiang Ren; Aiwu Li; Xiaoxia Chen; CaiCun 📂 Article 📅 2012 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 751 KB

8083 ORAL The use of a mobile phone base

8083 ORAL The use of a mobile phone based advanced symptom management system in the home monitoring and symptom management of chemotherapy related toxicities in patients with breast, lung and colorectal cancer: Patients' and clinicans' perceptions for supportive self care

✍ McCann, L.; Maguire, R.; Kearney, N.; Miller, M.; Taylor, L.; Sage, M.; Gray, P. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 56 KB

PD-147 A phase I study of a second gener

PD-147 A phase I study of a second generation antisenseoligonucleotide to clusterin (OGX-011) in combination with gemcitabine and cisplatin as first-line treatment for patients with advanced non-small cell lung cancer (NSCLC): Preliminary results

✍ Laskin, J.; Chi, K.; Melosky, B.; Sill, K.; Hao, D.; Canil, C.; Gleave, M.; Murr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 129 KB

769 Reducing health care burden for the

769 Reducing health care burden for the treatment of toxicity associated with pemetrexed or docetaxel in patients with advanced non-small cell lung cancer who previously received chemotherapy: application to the UK setting

✍ L. Bushill-Matthews; D. Jackson; M. Aristides; J. von Pawel; F. De Marines; R. G 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 147 KB

PCN43 THE COST OF TREATING GRADE 3/4 ADV

PCN43 THE COST OF TREATING GRADE 3/4 ADVERSE EVENTS RELATED TO FIRST-LINE THERAPY WITH BEVACIZUMAB PLUS CHEMOTHERAPY VERSUS CETUXIMAB PLUS CISPLATIN/VINORELBINE FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) IN FRANCE

✍ C Chouaid; A Vergnenegre; M Brunner; S Walzer 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

The impact of breast separation on radia

The impact of breast separation on radiation dose delivery to the ipsilateral lung as a result of respiratory motion quantified using free breathing and 4D-CT-based planning for radiotherapy to whole breast and regional lymphatics in patients with locally advanced breast cancers: results of Weill Cornell Medical College, New York

✍ T.E. Heineman; A. Sabbas; M.S. Delamerced; Y. Chiu; M. Smith; A.G. Wernicke 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 45 KB